Fig. 3
From: Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
Participation flow chart for the human study. Nineteen subjects were recruited and screened. Three subjects were excluded from the study: two due to high blood creatinine level and invisible veins, respectively, and one declined to participate after screening. Samples from two subjects were excluded for analysis due to technical reasons. IV intravenous